Phibro Animal Health, which manufactures food and medicine for farm animals, filed on Monday with the SEC to raise up to $230 million in an initial public offering. The Teaneck, NJ-based company, which was founded in 1946 and booked $662 million in sales for the 12 months ended December 31, 2013, plans to list on the NASDAQ under the symbol PAHC. Phibro Animal Health initially filed confidentially on January 13, 2014. BofA Merrill Lynch, Morgan Stanley and Barclays are the joint bookrunners on the deal. No pricing terms were disclosed.
